The Department of Health and Human Services announced Tuesday that it’s winding down $500 million in funding for the development of mRNA vaccines, which became most widely known during the COVID-19 pandemic.

The funding is in 22 contracts or awards under the Biomedical Advanced Research and Development Authority, known as BARDA.

"The data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,” HHS Secretary Robert F. Kennedy Jr. said in a statement. “We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.”

Kennedy went on to say in a video announcing the decision that the mRNA vaccines encouraged viral mutations and did not prevent infection – both points refuted by several scient

See Full Page